Clinical Trial

A Study for People with Gastroesophageal (Upper GI) Cancer - Symbiotic-GI-16

Event Main Image

Overview

Read about the Symbiotic-GI-16 clinical trial for people with gastroesophageal (upper GI) cancer.

(ClinicalTrials.gov Identifier: NCT07392892).

Who can take part?  

You may be eligible to participate in this clinical trial if you are aged 18 or older and:

  • Have been diagnosed with locally advanced or metastatic stomach and/or esophageal cancer
  • Have not received prior treatment for advanced or metastatic cancer
  • Your tumor has been diagnosed as “HER2-negative” and “PD-L1 positive

Clinical Trial
The Symbiotic-GI-16 clinical trial is evaluating a study medicine, given with standard chemotherapy treatment, in people with locally advanced or metastatic stomach and/or esophageal cancer.
Download
Clinical Trial
Arrow